(Q43118139)

14 November 2017

Association of low testosterone with metabolic syndrome and its components in middle-aged Japanese men. (English)

1 reference

14 November 2017

1 reference

1 reference

1 reference

Masahiro Akishita

1

1 reference

14 November 2017

Shiho Fukai

2

1 reference

14 November 2017

Masayoshi Hashimoto

3

1 reference

14 November 2017

Yumi Kameyama

4

1 reference

14 November 2017

Kazushi Nomura

5

1 reference

14 November 2017

Tetsuro Nakamura

6

1 reference

14 November 2017

Sumito Ogawa

7

1 reference

14 November 2017

Katsuya Iijima

8

1 reference

14 November 2017

Masato Eto

9

1 reference

14 November 2017

Yasuyoshi Ouchi

10

1 reference

14 November 2017

language of work or name

1 reference

26 March 2010

1 reference

14 November 2017

Hypertension Research

1 reference

14 November 2017

33

1 reference

14 November 2017

587-591

1 reference

14 November 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2010.43

14 November 2017

0 references

cites work

The metabolic syndrome as a concept of adipose tissue disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Endogenous sex hormones in men aged 40-80 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Serum testosterone levels and arterial blood pressure in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Sex hormones, inflammation and the metabolic syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Endogenous sex hormones and metabolic syndrome in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Aging, androgens, and the metabolic syndrome in a longitudinal study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Low testosterone level is an independent determinant of endothelial dysfunction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men--the Tanno and Sobetsu Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Prevalence of metabolic syndrome and optimal waist circumference cut-off values in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Androgen deficiency, diabetes, and the metabolic syndrome in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

Is metabolic syndrome the main threat to human health in the twenty-first century?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

7 January 2021

Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

7 January 2021

Metabolic syndrome--definition and diagnostic criteria in Japan

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

7 January 2021

Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

7 January 2021

Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.43

7 January 2021

Identifiers

DOI

10.1038/HR.2010.43

1 reference

14 November 2017

1 reference